Candriam Equities L Oncology Impact R USD CapRegistreer u om de ratings zichtbaar te maken |
Hoe heeft dit fonds gepresteerd? | 31-03-2024 |
Ontwikkeling van EUR 1000 (EUR) | Uitgebreide Grafiek |
Fonds | 21,4 | 11,2 | -3,9 | -2,4 | 9,6 | |
+/-Cat | 10,2 | -5,5 | 5,9 | -1,6 | 2,9 | |
+/-Idx | - | -14,8 | -4,0 | -2,2 | 0,1 | |
Categorie: Aandelen Sector Farmacie & Gezondheid | ||||||
Categorie Benchmark: Morningstar Gbl Health TME ... |
Kerngegevens | ||
Koers 18-04-2024 | USD 264,81 | |
Rendement 1 Dag | -0,49% | |
Morningstar Categorie™ | Aandelen Sector Farmacie & Gezondheid | |
Vestigingsland | Luxemburg | |
ISIN | LU1864482788 | |
Grootte Fonds (Mil) 18-04-2024 | USD 1759,32 | |
Grootte Fondsklasse (Mil) 18-04-2024 | USD 5,06 | |
Aankoopkosten (Max) | 3,50% | |
Lopende Kosten Factor 01-03-2024 | 1,11% |
Beleggingsdoelstelling: Candriam Equities L Oncology Impact R USD Cap |
The objective of the sub-fund is to use discretionary management to benefit from the performance of the market in global equities of companies in the field of oncology (cancer research, diagnosis, treatment, etc.) in order to respond to one of the serious long-term challenges of sustainable development. The subfund therefore seeks to produce a return for investors while generating a positive social impact over the long term, by selecting companies that address certain societal challenges and mobilise resources in the fight against cancer. |
Returns | |||||||||||||
|
Management | ||
Naam manager Aanvangsdatum | ||
Rudi Van den Eynde 15-11-2018 | ||
Linden Thomson 29-02-2024 | ||
Oprichtingsdatum 15-11-2018 |
Advertentie |
Categorie Benchmark | |
Benchmark van het fonds | Benchmark Morningstar |
MSCI World NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Waar belegt het fonds in? Candriam Equities L Oncology Impact R USD Cap | 31-03-2024 |
|
|
Top 5 posities | Sector | % |
Merck & Co Inc | Gezondheidszorg | 9,30 |
AstraZeneca PLC | Gezondheidszorg | 7,67 |
Novartis AG Registered Shares | Gezondheidszorg | 6,46 |
Roche Holding AG | Gezondheidszorg | 5,47 |
Siemens Healthineers AG Register... | Gezondheidszorg | 5,24 |
Toename Afname Nieuw t.o.v. vorige portefeuille | ||
Candriam Equities L Oncology Impact R USD Cap |